Trial intelligence / Profile preview

Single-dose Revolade administration in healthy Japanese adult males

jRCT1080222265Phase 1

Sponsor
Mitsubishi Chemical Group
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of eltrombopag, sponsored by Mitsubishi Chemical Group.

02

Drugs

eltrombopag

Beyond the preview

Go deeper on jRCT1080222265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call